Evidence map›Paper›PMID 31921190›Full record

Trial reportFrontiers in immunology2019

Ataxia Telangiectasia Diagnosed on Newborn Screening-Case Cohort of 5 Years' Experience.

Amarilla B Mandola, Brenda Reid, Raga Sirror, Rae Brager, Peter Dent, Pranesh Chakroborty, Dennis E Bulman, Chaim M Roifman

Open access · goldAbstract readCase ReportsClinical Trial
In one paragraph

Trial report in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Update on Recommendations for Cancer Screening and Surveillance in Children with Genomic Instability Disorders.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Review
  8. Utilization of next-generation sequencing to define the role of heterozygousThe journal of allergy and clinical immunology. Global · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 1 country.

Amarilla B MandolaDivision of Immunology and Allergy, Department of Paediatrics, The Hospital for Sick Children and the University of Toronto, Toronto, ON, Canada.
Brenda ReidDivision of Immunology and Allergy, Department of Paediatrics, The Hospital for Sick Children and the University of Toronto, Toronto, ON, Canada.
Raga SirrorPaediatric Allergy/Immunology, Thunder Bay Regional Health Sciences Center, North Ontario School of Medicine, Thunder Bay, ON, Canada.
Rae BragerDivision of Rheumatology, Immunology, and Allergy, Department of Paediatrics, McMaster Children's Hospital, McMaster University, Hamilton, ON, Canada.
Peter DentDivision of Rheumatology, Immunology, and Allergy, Department of Paediatrics, McMaster Children's Hospital, McMaster University, Hamilton, ON, Canada.
Pranesh ChakrobortyDepartment of Pediatrics, CHEO Research Institute and Newborn Screening Ontario, University of Ottawa, Ottawa, ON, Canada.
Dennis E BulmanDepartment of Pediatrics, CHEO Research Institute and Newborn Screening Ontario, University of Ottawa, Ottawa, ON, Canada.
Chaim M RoifmanDivision of Immunology and Allergy, Department of Paediatrics, The Hospital for Sick Children and the University of Toronto, Toronto, ON, Canada.
McMaster University · CAHospital for Sick Children · CANewborn Screening Ontario · CASickKids Foundation · CAThunder Bay Regional Health Sciences Centre · CAUniversity of Ottawa · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ataxia telangiectasia (AT) is a genetic condition caused by mutations involving

Indexed as

Ataxia TelangiectasiaAtaxia Telangiectasia Mutated ProteinsMutationNeonatal ScreeningSevere Combined ImmunodeficiencyB-LymphocytesCase-Control StudiesHumansImmunoglobulins, IntravenousInfantInfant, NewbornMaleOntarioT-LymphocytesVaccinationWhole Genome SequencingAtaxia Telangiectasia Mutated ProteinsATM protein, humanImmunoglobulins, Intravenousataxia telangiectasialymphopenianewborn screenprimary immunodeficiencyTRECs

Identifiers

PMID31921190
PMCPMC6932992
OpenAlexW2994917050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.